IP Library › Granted Patent US 11,583,610
Granted Patent B2
US 11,583,610 · App. 16/956,968 · Granted Feb 21, 2023

Spray-dried thrombin and methods of using and making spray-dried thrombin

Inventors: Alexander Wesley Scott (Chicago, IL); Paul Jeffrey Sanders (Greendale, WI); Alyssa Sanders (Mount Pleasant, WI); Adam Christopher Mercer (Chicago, IL)
Assignees: Baxter International Inc.; Baxter Healthcare SA
A61L24/104A61L24/0031A61L24/108A61L2400/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,583,610
App. No.
16/956,968
Granted
Feb 21, 2023
Kind
B2
Abstract

Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.

Claims (8)

1. A rapidly reconstitutable thrombin powder comprising thrombin and from about 2.2 to 2.5% by weight of albumin, said thrombin powder being reconstitutable in a saline diluent in less than 60 seconds, said thrombin powder being free of carbohydrate, trehalose and mannitol.

2. A rapidly reconstitutable thrombin powder as recited in claim 1 comprising 75%-90% by weight total protein based on total solids of the thrombin powder.

3. A rapidly reconstitutable thrombin powder as recited in claim 1 , having a particle size of from about 0.01 mm to 0.1 mm.

4. A rapidly reconstitutable thrombin powder as recited in claim 1 prepared by spray drying.

5. A rapidly reconstitutable thrombin powder as recited in claim 1 , prepared by asceptic spray drying.

6. A hemostatic composition comprising a spray-dried thrombin material and less than 2.2% to 2.5% by weight albumin, and wherein the hemostatic composition does not include carbohydrates.

7. The hemostatic composition according to claim 6 , wherein the spray-dried thrombin material is aseptically spray-dried.

8. The hemostatic composition according to claim 6 , wherein the spray-dried thrombin material comprises 75 to 90% by weight total protein based on the total solids content of the material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: SCOTT, ALEXANDER WESLEY; SANDERS, PAUL JEFFREY; SANDERS, ALYSSA; MERCER, ADAM CHRISTOPHER
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 053012/0567 →
Continuity (3)
Provisional Application 62611963 · Dec 29, 2017
Provisional Application 62771936 · Nov 27, 2018
Related Publication 20210379240A1 · Dec 9, 2021
Cited By (1)
US 12,343,385